Radiation therapy following surgery is the most effective treatment for malignant brain tumors, but clinically admissible radiation doses are limited because the radiation also damages normal tissue. If that damage could be ameliorated, radiation doses delivered to brain tumors might be increased and therapeutic efficacy enhanced. Radiation-induced brain damage often includes damage to the cerebral vasculature, as evidenced by prominent blood-brain barrier breakdown and cerebral edema. In this study, we wish to elucidate the mechanisms responsible for the sensitivity to radiation of the cells composing the cerebral vascular system. This work could suggest possible therapies directed toward ameliorating the radiation sensitivity of normal brain. We hypothesize that the differing endogenous levels of antioxidants, such as ascorbate, and pro-oxidants, such as the naturally occurring free radical nitric oxide (NO), are responsible for any differential radiosensitivity of cerebrovascular cells: and that modification of endogenous oxidant levels can modulate radiosensitivity. To test this hypothesis, we will examine the radiation sensitivity of primary cultures of cerebral endothelial cells, astrocytes, and pericytes from normal rats and mice and transgenic mice overexpressing human copper-zinc (CuZn)-superoxide dismutase (SOD) in the presence of various antioxidants and pro-oxidants.
Our specific aims are: 1) to quantify the susceptibility of primary cell cultures of rat cerebral endothelial cells, astrocytes, and pericytes to radiation-induced injury; 2) to correlate radiation-induced injury to cerebrovascular cells with levels of antioxidants; 3) to determine whether physiologic stimulation of NO production enhances radiation-induced injury to cerebral endothelial cells, to determine whether blockage of NO can ameliorate such injury, and to establish any role the superoxide anion may have in NO-mediated damage; 4) to elucidate the molecular mechanism by which modification of endogenous antioxidant systems (SOD, catalase, and glutathione peroxidase) or production of NO modulate the degree of radiation-induced cell damage; and, 5) to determine whether the level of radiation-induced injury is altered when cells are grown as mixed cultures (endothelial-pericyte and endothelial-astrocyte), and whether any modification of the response is due to cell-to-cell transfer of antioxidants, to the induction of antioxidant production, or to transfer of free radicals such as NO.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA013525-26S1
Application #
6101546
Study Section
Project Start
1998-06-08
Project End
2000-09-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
26
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rodriguez, Fausto J; Tihan, Tarik; Lin, Doris et al. (2014) Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol 38:1058-70
Chang, Susan M; Parney, Ian F; Huang, Wei et al. (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-64
Parney, Ian F; Kunwar, Sandeep; McDermott, Michael et al. (2005) Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 102:267-75
Prados, Michael D; Seiferheld, Wendy; Sandler, Howard M et al. (2004) Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58:1147-52
Levin, Victor A; Hess, Kenneth R; Choucair, Ali et al. (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981-90
McKnight, Tracy R; von dem Bussche, Mary H; Vigneron, Daniel B et al. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802
Hamel, W; Zirkel, D; Mehdorn, H M et al. (2001) (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells. Cancer Gene Ther 8:388-96
Simmons, M L; Lamborn, K R; Takahashi, M et al. (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61:1122-8
Hamel, W; Dazin, P; Israel, M A (1996) Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173-81
Hamel, W; Magnelli, L; Chiarugi, V P et al. (1996) Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 56:2697-702

Showing the most recent 10 out of 14 publications